menu search

ESLOY / EssilorLuxottica Unsponsored ADR (ESLOY) Upgraded to Strong Buy: Here's What You Should Know

EssilorLuxottica Unsponsored ADR (ESLOY) Upgraded to Strong Buy: Here's What You Should Know
EssilorLuxottica Unsponsored ADR (ESLOY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). Read More
Posted: Feb 3 2023, 13:33
Author Name: Zacks Investment Research
Views: 110872

ESLOY News  

EssilorLuxottica Is A Perfect Combination Of Tech, Pharma, And Fashion

By Seeking Alpha
October 7, 2023

EssilorLuxottica Is A Perfect Combination Of Tech, Pharma, And Fashion

EssilorLuxottica and Meta have unveiled the second generation of smart glasses, featuring live-streaming and AI applications. Better numbers in Essilo more_horizontal

EssilorLuxottica: My Biggest European Discretionary Investment

By Seeking Alpha
October 7, 2023

EssilorLuxottica: My Biggest European Discretionary Investment

EssilorLuxottica is the world's largest eyewear company, owning over 150 world-famous brands in prescription eye-wear and sunglasses. The Asia-Pacific more_horizontal

EssilorLuxottica: Long-Term Outperformance, Put On Your Sunglasses And Buy

By Seeking Alpha
July 10, 2023

EssilorLuxottica: Long-Term Outperformance, Put On Your Sunglasses And Buy

I revisit EssilorLuxottica SA, noting its near-equal performance to the S&P 500 with a RoR of 9.93% versus 10.03%. Despite not outperforming the S&P 5 more_horizontal

ESLOY vs. PODD: Which Stock Is the Better Value Option?

By Zacks Investment Research
June 28, 2023

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either EssilorLuxottica Unsponsored ADR (ESLOY) or Insulet (PODD) more_horizontal

All You Need to Know About EssilorLuxottica Unsponsored ADR (ESLOY) Rating Upgrade to Strong Buy

By Zacks Investment Research
June 19, 2023

All You Need to Know About EssilorLuxottica Unsponsored ADR (ESLOY) Rating Upgrade to Strong Buy

EssilorLuxottica Unsponsored ADR (ESLOY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Za more_horizontal

ESLOY or PODD: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
June 12, 2023

ESLOY or PODD: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both EssilorLuxottica Unsponsored ADR (ESLOY) and Insulet (PODD). But more_horizontal

EssilorLuxottica Unsponsored ADR (ESLOY) Upgraded to Strong Buy: Here's Why

By Zacks Investment Research
April 28, 2023

EssilorLuxottica Unsponsored ADR (ESLOY) Upgraded to Strong Buy: Here's Why

EssilorLuxottica Unsponsored ADR (ESLOY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Za more_horizontal

EssilorLuxottica: Time To Put This One On Your Watchlist, Even A 'Buy'

By Seeking Alpha
March 3, 2023

EssilorLuxottica: Time To Put This One On Your Watchlist, Even A 'Buy'

EssilorLuxottica is my latest foray into the consumer Discretionary segment, namely in the industry of Eyewear and eye care. EssilorLuxottica is a ver more_horizontal


Search within

Pages Search Results: